Fidia Boosts Share Capital After Convertible Bond Conversions

Fidia Spa ( (IT:FDA) ) has issued an announcement.

Fidia S.p.A. has announced a change in its share capital following the conversion of a series of recently issued convertible bonds into ordinary shares. The company’s share capital has risen from €9,847,761.90 to €10,687,761.90, with the total number of ordinary shares increasing from 30,298,485 to 45,042,927, all admitted to trading on Euronext Milan.

The capital increase, amounting to €840,000 and corresponding to the issue of 14,744,442 new shares, reflects the progressive execution of the convertible bond loan approved in January 2026. The updated Articles of Association and related certification have been filed with the Turin Companies’ Register, formalising the enlarged equity base and potential broadening of the shareholder structure.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in the design, production and marketing of high-performance integrated milling systems. The group, with over 50 years of experience and around 135 employees, focuses on solutions for the mould sector in the automotive industry and the aerospace sector, offering numerical controls, high-speed milling systems and CAM software for complex shapes.

Average Trading Volume: 1,312,212

Technical Sentiment Signal: Strong Sell

Current Market Cap: €842K

See more insights into FDA stock on TipRanks’ Stock Analysis page.